ITTO20020286A1 - USE OF THE PROTEIN P17 ISOLATED FOR THE PREPARATION OF A MEDICATION SUITABLE TO INHIBIT THE IMMUNOSTIMULATING EFFECTS THAT THE PROTEIN PRODUCED D - Google Patents

USE OF THE PROTEIN P17 ISOLATED FOR THE PREPARATION OF A MEDICATION SUITABLE TO INHIBIT THE IMMUNOSTIMULATING EFFECTS THAT THE PROTEIN PRODUCED D

Info

Publication number
ITTO20020286A1
ITTO20020286A1 IT2002TO000286A ITTO20020286A ITTO20020286A1 IT TO20020286 A1 ITTO20020286 A1 IT TO20020286A1 IT 2002TO000286 A IT2002TO000286 A IT 2002TO000286A IT TO20020286 A ITTO20020286 A IT TO20020286A IT TO20020286 A1 ITTO20020286 A1 IT TO20020286A1
Authority
IT
Italy
Prior art keywords
protein
inhibit
isolated
preparation
immunostimulating effects
Prior art date
Application number
IT2002TO000286A
Other languages
Italian (it)
Inventor
Arnaldo Caruso
Original Assignee
Medestea Int Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medestea Int Spa filed Critical Medestea Int Spa
Priority to IT2002TO000286A priority Critical patent/ITTO20020286A1/en
Publication of ITTO20020286A0 publication Critical patent/ITTO20020286A0/en
Priority to AU2003219101A priority patent/AU2003219101A1/en
Priority to PCT/EP2003/003177 priority patent/WO2003082908A2/en
Publication of ITTO20020286A1 publication Critical patent/ITTO20020286A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
IT2002TO000286A 2002-03-29 2002-03-29 USE OF THE PROTEIN P17 ISOLATED FOR THE PREPARATION OF A MEDICATION SUITABLE TO INHIBIT THE IMMUNOSTIMULATING EFFECTS THAT THE PROTEIN PRODUCED D ITTO20020286A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT2002TO000286A ITTO20020286A1 (en) 2002-03-29 2002-03-29 USE OF THE PROTEIN P17 ISOLATED FOR THE PREPARATION OF A MEDICATION SUITABLE TO INHIBIT THE IMMUNOSTIMULATING EFFECTS THAT THE PROTEIN PRODUCED D
AU2003219101A AU2003219101A1 (en) 2002-03-29 2003-03-27 Use of the p17 protein of hiv in isolated form for the preparation of a medicament for administration to hiv seropositive patients, as well as pharmaceutical compositions comprising said protein
PCT/EP2003/003177 WO2003082908A2 (en) 2002-03-29 2003-03-27 Use of the p17 protein of hiv in isolated form for the preparation of a medicament for administration to hiv seropositive patients, as well as pharmaceutical compositions comprising said protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002TO000286A ITTO20020286A1 (en) 2002-03-29 2002-03-29 USE OF THE PROTEIN P17 ISOLATED FOR THE PREPARATION OF A MEDICATION SUITABLE TO INHIBIT THE IMMUNOSTIMULATING EFFECTS THAT THE PROTEIN PRODUCED D

Publications (2)

Publication Number Publication Date
ITTO20020286A0 ITTO20020286A0 (en) 2002-03-29
ITTO20020286A1 true ITTO20020286A1 (en) 2003-09-29

Family

ID=27638968

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2002TO000286A ITTO20020286A1 (en) 2002-03-29 2002-03-29 USE OF THE PROTEIN P17 ISOLATED FOR THE PREPARATION OF A MEDICATION SUITABLE TO INHIBIT THE IMMUNOSTIMULATING EFFECTS THAT THE PROTEIN PRODUCED D

Country Status (3)

Country Link
AU (1) AU2003219101A1 (en)
IT (1) ITTO20020286A1 (en)
WO (1) WO2003082908A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITTO20080027A1 (en) 2008-01-15 2009-07-16 Medestea Res & Production S P A SHAPED FORM OF HIV PROTEIN P17.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0293792A3 (en) * 1987-06-01 1990-01-17 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus gag-encoded proteins
DK643188A (en) * 1987-11-24 1989-05-25 Smithkline Biolog EXPRESSION OF HIV PROTEINS IN E.COLI AND S.CEREVISIAE
GB9703802D0 (en) * 1997-02-24 1997-04-16 Kingsman Susan M Anti-hiv peptides and proteins
RU2337922C9 (en) * 2001-08-07 2009-02-10 Медести Интернационале С.Р.Л. ISOLATED POLYPEPTIDES BASED ON NEUTRALISING OF PROTEIN p17 OF HIV VIRUS, USED AS VACCINES, AND NEUTRALISING ANTI-p17-ANTIBODIES, SPECIFICALLY RECOGNISING SAID NEUTRALISING

Also Published As

Publication number Publication date
WO2003082908A3 (en) 2004-03-25
ITTO20020286A0 (en) 2002-03-29
AU2003219101A1 (en) 2003-10-13
AU2003219101A8 (en) 2003-10-13
WO2003082908A2 (en) 2003-10-09

Similar Documents

Publication Publication Date Title
DK1567112T3 (en) Thiazolidine-4-ones to inhibit hYAK3 proteins
NO20033973L (en) Seismic mapping to the sea
NO20041018L (en) Antibodies to OPGL
ATE517855T1 (en) ANTIBODIES TO CHEMOTACTIC MONOCYTE PROTEINS
AU2003286922A8 (en) Analysis of geometric surfaces by conformal structure
DE60213607D1 (en) EASY TO FEED DONATE
IS6986A (en) Liquid pharmaceutical composition
ITMI20040076A1 (en) PROCEDURE FOR THE PREPARATION OF LOW DEGREE POLYBUTADIENE
IS8376A (en) Seed protein production
ITMI20020189A0 (en) COMPOSITION FOR PHARMACEUTICAL OR DIETARY USE TO CONTRACT HAIR LOSS
DE60220625D1 (en) Improvements to turbomachinery injectors
DE60235195D1 (en) VITAMIN D ANALOGS
FR2842873B1 (en) CARBURETOR STRUCTURE
EE200400045A (en) Technical synthesis method for the preparation of tropenol
ITTO20020286A1 (en) USE OF THE PROTEIN P17 ISOLATED FOR THE PREPARATION OF A MEDICATION SUITABLE TO INHIBIT THE IMMUNOSTIMULATING EFFECTS THAT THE PROTEIN PRODUCED D
ITMI20032141A1 (en) PROCEDURE TO INFLUENCE THE MASS CONSTANCE OF
ITMI20031994A1 (en) PROCEDURE FOR THE PREPARATION OF FLUDARABINA FOSFATO
FI20010808A0 (en) Procedure for pointing to a point in a measurement space
ITMI20030018A1 (en) PROCEDURE FOR THE PREPARATION OF SINGLE COMPOUNDS
IS8103A (en) Pharmaceutical preparation containing macrolide immune response
ITMI20030019A1 (en) PROCEDURE FOR THE PREPARATION OF SINGLE COMPOUNDS
ITTN20020004U1 (en) SELF-LEVELING SCALE USEFUL TO OVERCOME VARIABLE DIFFERENCES
NO20010865D0 (en) Global seismic connections
ITAQ20030001U1 (en) COCCARDA MANGIACONFETTO FLO REAL DECORATIVE PACKAGING PROCEDURE THAT ALLOWS TO EXTRACT THE CONFETTO (OR SIMILAR PRODUCTS) WITHOUT ALTERING THE DECORATIVE STRUCTURE OF THE COCCARDA
ITPC20030026A1 (en) CEMENTITIOUS COMPOSITION FOR THE PREPARATION OF